122 related articles for article (PubMed ID: 4181038)
1. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation].
Krzywdziński K; Jedrzejewski M; Teter J
Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038
[No Abstract] [Full Text] [Related]
2. [Sequential therapy].
Annee Endocrinol; 1967; 19():97-102. PubMed ID: 4173491
[No Abstract] [Full Text] [Related]
3. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
Ebeling K; Kühndel K; Rothe K; Canzler E
Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1275-8. PubMed ID: 4111418
[No Abstract] [Full Text] [Related]
4. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
Bernard I
Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
[No Abstract] [Full Text] [Related]
5. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
Kalchauer B
Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
[No Abstract] [Full Text] [Related]
6. [Sequential treatment. Experimental and clinical study].
Di Paola G; Mendizábal A; Usubiaga I; Ortega F
Rev Argent Endocrinol Metab; 1966 Sep; 12(3):158-72. PubMed ID: 4170552
[No Abstract] [Full Text] [Related]
7. [Menstruation disorders due to Ovosiston medication].
Kühndel K; Ebeling K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
[No Abstract] [Full Text] [Related]
8. [Combined estrogen-progestagen-therapy in menstruation anomalies].
Akasu F
Arch Gynakol; 1971 Jun; 211(1):191-3. PubMed ID: 4103779
[No Abstract] [Full Text] [Related]
9. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
Müller R; Kempf HJ; Eckert L
Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
[No Abstract] [Full Text] [Related]
10. [Chlormadinone therapy of menstruation disorders].
Stanev S; Trepechov S
Akush Ginekol (Sofiia); 1973; 12(2):110-5. PubMed ID: 4128262
[No Abstract] [Full Text] [Related]
11. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
Krause W; Böhm W; Müller W
Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
[No Abstract] [Full Text] [Related]
12. A new progestogen-estrogen combination for gynecologic therapy and contraception.
Linthorst G
Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
[No Abstract] [Full Text] [Related]
13. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
[No Abstract] [Full Text] [Related]
14. ["Turignost" for early pregnancy test and short treatment of secondary amenorrhea].
Müller R
Dtsch Gesundheitsw; 1970 Feb; 25(6):252-4. PubMed ID: 4108414
[No Abstract] [Full Text] [Related]
15. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations].
Göretzlehner G; Wilken H
Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480
[TBL] [Abstract][Full Text] [Related]
16. [Histologic and colpocytologic aspects of the endometrium associated with HMG and HCG therapy].
Cianci S; Di Leo S; Marotta N
Minerva Ginecol; 1968 Sep; 20(17):1449-51. PubMed ID: 5739904
[No Abstract] [Full Text] [Related]
17. [Clinical application of Sophia-A, combined low-dosage preparation of norethisterone and mestranol].
Akasu F; Akasofu K; Hayashi I; Fujii I; Shimada H
Horumon To Rinsho; 1969 Oct; 17(10):871-5. PubMed ID: 5390548
[No Abstract] [Full Text] [Related]
18. [CLINICAL USE OF A NEW ORAL PROGESTOGEN: CHLORMADINONE].
DELCORRAL F; ARTUZ A; SALCEDO CA; ERAZO JV; ANGEL G
Rev Colomb Obstet Ginecol; 1963; 14():605-23. PubMed ID: 14117499
[No Abstract] [Full Text] [Related]
19. [Use of Ovosiston in prevention of bleeding after electroconization].
Malachowski Z; Kaliński R
Pol Tyg Lek; 1970 Jul; 25(30):1138-9. PubMed ID: 4194911
[No Abstract] [Full Text] [Related]
20. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
Ebeling K; Kühndel K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
